Jennifer Porcelli
Investor Relations Contact bei BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.
Profil
Jennifer Porcelli is currently working as the Vice President of Investor Relations at Biohaven Pharmaceutical Holding Co. Ltd.
and Biohaven Ltd.
She previously held positions as the Managing Director at Solebury Strategic Communications LLC and as the Head of Investor Relations at Centessa Pharmaceuticals LLC.
Ms. Porcelli completed her undergraduate degree at Georgetown University.
Aktive Positionen von Jennifer Porcelli
| Unternehmen | Position | Beginn |
|---|---|---|
| BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | Investor Relations Contact | 01.01.2022 |
| BIOHAVEN LTD. | Investor Relations Contact | 01.02.2022 |
Ehemalige bekannte Positionen von Jennifer Porcelli
| Unternehmen | Position | Ende |
|---|---|---|
Solebury Strategic Communications LLC
 Solebury Strategic Communications LLC Miscellaneous Commercial ServicesCommercial Services Solebury Trout LLC engages in communications services. The company is headquartered in the United States. | Corporate Officer/Principal | - |
Centessa Pharmaceuticals, Inc.
 Centessa Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Centessa Pharmaceuticals Plc, Centessa Pharmaceuticals LLC is a private company that manufactures medicines. The company is based in Horsham, PA. The CEO of the company is Saurabh Saha. | Investor Relations Contact | - |
Ausbildung von Jennifer Porcelli
| Georgetown University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| BIOHAVEN LTD. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Biohaven Pharmaceutical Holding Co. Ltd.
 Biohaven Pharmaceutical Holding Co. Ltd. Pharmaceuticals: MajorHealth Technology Biohaven Pharmaceutical Holding Co. Ltd. is a clinical-stage biopharmaceutical company, which engages in the research and development of late-stage product candidates targeting neurological diseases, including rare disorders. It focuses on a pipeline of product candidates that represent mechanistic platforms, calcitonin gene-related peptide receptor antagonists, and glutamate modulators. The company was founded in September 2013 and is headquartered in New Haven, CT. | Health Technology |
Solebury Strategic Communications LLC
Solebury Strategic Communications LLC Miscellaneous Commercial ServicesCommercial Services Solebury Trout LLC engages in communications services. The company is headquartered in the United States. | Commercial Services |
Centessa Pharmaceuticals, Inc.
Centessa Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Centessa Pharmaceuticals Plc, Centessa Pharmaceuticals LLC is a private company that manufactures medicines. The company is based in Horsham, PA. The CEO of the company is Saurabh Saha. | Health Technology |
